Invention Grant
- Patent Title: Intestinal immune-enhancing agent, food product, and medicament
-
Application No.: US17476131Application Date: 2021-09-15
-
Publication No.: US11896043B2Publication Date: 2024-02-13
- Inventor: Tadashi Takeuchi , Eiji Miyauchi , Shu Shimamoto , Akinobu Matsuyama , Hiroshi Ohno
- Applicant: DAICEL CORPORATION
- Applicant Address: JP Osaka
- Assignee: DAICEL CORPORATION
- Current Assignee: DAICEL CORPORATION
- Current Assignee Address: JP Osaka
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP 17207154 2017.10.26
- Main IPC: A23L33/24
- IPC: A23L33/24 ; A61K31/717 ; G06F17/18
Abstract:
Object of the present invention is to provide an intestinal immune-enhancing agent that can sufficiently increase IgA in the intestinal tract with a low dose while maintaining an increased amount of IgA for an extended period of time. Provided is an intestinal immune-enhancing agent containing a cellulose acetate that has a total degree of acetyl substitution from 0.4 to 1.1.
Public/Granted literature
- US20220061372A1 INTESTINAL IMMUNE-ENHANCING AGENT, FOOD PRODUCT, AND MEDICAMENT Public/Granted day:2022-03-03
Information query
